This session will explore the evolving landscape of Health Technology Assessment (HTA), featuring two distinguished speakers:

Rui Santos Ivo, President of Infarmed, the Portuguese National Authority for Medicines and Health Products, will provide insights on how regulatory frameworks and HTA are adapting to the rapid advancements in healthcare innovation.

Elena Petelos, Vice-President of the EUPHA HTA Section and Co-Chair of the RWE and Artificial Intelligence Interest Group at HTAi, will delve into the integration of real-world evidence (RWE) and AI in shaping the future of HTA, emphasizing their potential to enhance decision-making processes.

Join us for an engaging discussion on the challenges and opportunities that lie ahead in this crucial field.

свернуть